Re: Zenith Capital Corp. Announces Annual and Special Meeting Webcast Details

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith Capital Corp. Announces Annual and Special Meeting Webcast Details

posted on Dec 07, 2016 09:06PM

Kelsee is correct. Both Resverlogix and Zenith have AGMs on Dec 15th and both are followed by webcast corporate updates. So 2 AGMs and 2 webcast corporate updates.